1. Home
  2. RGNX vs EQV Comparison

RGNX vs EQV Comparison

Compare RGNX & EQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • EQV
  • Stock Information
  • Founded
  • RGNX 2008
  • EQV 2024
  • Country
  • RGNX United States
  • EQV United States
  • Employees
  • RGNX N/A
  • EQV N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • EQV
  • Sector
  • RGNX Health Care
  • EQV
  • Exchange
  • RGNX Nasdaq
  • EQV Nasdaq
  • Market Cap
  • RGNX 459.1M
  • EQV 443.1M
  • IPO Year
  • RGNX 2015
  • EQV 2024
  • Fundamental
  • Price
  • RGNX $7.62
  • EQV $9.94
  • Analyst Decision
  • RGNX Strong Buy
  • EQV
  • Analyst Count
  • RGNX 12
  • EQV 0
  • Target Price
  • RGNX $36.00
  • EQV N/A
  • AVG Volume (30 Days)
  • RGNX 1.7M
  • EQV 141.6K
  • Earning Date
  • RGNX 11-06-2024
  • EQV 01-01-0001
  • Dividend Yield
  • RGNX N/A
  • EQV N/A
  • EPS Growth
  • RGNX N/A
  • EQV N/A
  • EPS
  • RGNX N/A
  • EQV N/A
  • Revenue
  • RGNX $84,327,000.00
  • EQV N/A
  • Revenue This Year
  • RGNX $2.34
  • EQV N/A
  • Revenue Next Year
  • RGNX $243.67
  • EQV N/A
  • P/E Ratio
  • RGNX N/A
  • EQV N/A
  • Revenue Growth
  • RGNX N/A
  • EQV N/A
  • 52 Week Low
  • RGNX $7.21
  • EQV $9.88
  • 52 Week High
  • RGNX $28.80
  • EQV $9.98
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 36.08
  • EQV N/A
  • Support Level
  • RGNX $8.06
  • EQV N/A
  • Resistance Level
  • RGNX $10.52
  • EQV N/A
  • Average True Range (ATR)
  • RGNX 0.76
  • EQV 0.00
  • MACD
  • RGNX -0.19
  • EQV 0.00
  • Stochastic Oscillator
  • RGNX 12.39
  • EQV 0.00

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About EQV EQV Ventures Acquisition Corp.

EQV Ventures Acquisition Corp is a blank check company.

Share on Social Networks: